security check required facebookjoin or log into facebook   email or phonepasswordforgot accountlog indo you want to join facebooksign upsign upsecurity checkplease enter the text belowcant read the text abovetry another text or an audio captchatext in the boxwhats thissecurity checkthis is a standard security test that we use to prevent spammers from creating fake accounts and spamming userssubmitenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook   insider trading  kalergis david g  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  kalergis david g select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm na diffusion pharmaceuticals inc dffn kalergis david gchairman and ceodirector   direct view option award  pm na diffusion pharmaceuticals inc dffn kalergis david gchairman and ceodirector   direct view option award  pm nana restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm nana restorgenex corp resx kalergis david gchairman and ceodirector   indirect view option award  pm  restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view option award  pm na restorgenex corp resx kalergis david gchairman and ceodirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  david kalergis  wikipedia david kalergis from wikipedia the free encyclopedia jump to navigation search david kalergis born december   is an american life sciences entrepreneur and the cofounder and chief executive officer of diffusion pharmaceuticals inc a charlottesville virginia usbased biotechnology and pharmaceutical company he cofounded the company in  with american chemical engineer john l gainer kalergis became diffusions ceo in  a position in which he has drawn extensively on his career in law business and clinical trials implementation under kalergis’ leadership diffusion pharmaceuticals has been cited for advancing improved cancer treatments and is currently conducting multicenter clinical trials of a novel therapeutic for brain cancers including glioblastoma multiforme david kalergis contents  education and career  other activities  awards and books  references education and careeredit kalergis received a ba degree in psychology in  and jd and mba degrees in  from the university of virginia he subsequently worked with the new yorkbased law firm dewey ballantine bushby palmer  wood maintaining that association until  when he became president and general counsel of designs importexport ltd from  to  he was consultant director of business development and general counsel to the contract research organization pharmaceutical research associates pra inc while with pra he was involved in numerous pharmaceutical development projects through the preclinical clinical and postmarketing stages in  kalergis was appointed director of university of virginia gateway a program to establish stronger ties between industry and academia particularly in the area of life sciences his efforts have been cited in advancing relationships between the hightechnology business and academic sectors both regionally  and internationally it was through his association with the university of virginia that kalergis met gainer who was at that time a professor of chemical engineering leading to their collaboration in the founding of diffusion pharmaceuticals kalergis is also a graduate of the harvard business school’s leadership and strategy in biotechnology and pharmaceuticals program other activitiesedit kalergis is a founding director of publicly traded virginia national bank where he was chairman of the assets and liabilities committee and a member of the audit committee he is a former member of the boards of directors of the virginia biotechnology association the virginia piedmont technology council and the computerskids program in charlottesville virginia he is a member of the new york and virginia state bar associations awards and booksedit kalergis received the virginia piedmont technology councils navigator award in  his and gainers work at diffusion pharmaceuticals was acknowledged in  when the company received the virginia healthcare innovators “medical product or device” award kalergis is the author of the role of the university in the commercialization of biotechnology  referencesedit  a b c d david kalergis walker research retrieved november     a b david kalergis forbes retrieved november     two local firms head to clinical trial stage for cancer treatment medications the daily progress february   retrieved december     area biotech groups lead the charge the daily progress february   retrieved december     company overview of diffusion pharmaceuticals llc bloomberg businessweek retrieved november     safety and efficacy study of trans sodium crocetinate tsc with concomitant radiation therapy and temozolomide in newly diagnosed glioblastoma gbm clinicaltrialsgov november  retrieved september     a b c d executive profile david g kalergis jd mba bloomberg businessweek retrieved november     virginia gateway in the news gateway  archived from the original on april   retrieved december     uva building japanese partnerships patent foundation opens licensing office in kobe insideuva january –  archived from the original on december   retrieved december     diffusion pharmaceuticals wins  va healthcare innovators award virginia biotechnology association retrieved october    retrieved from httpsenwikipediaorgwindexphptitledavidkalergisoldid categories american chief executivesuniversity of virginia school of law alumniuniversity of virginia darden school of business alumni birthsliving people navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david kalergis  wikipedia david kalergis from wikipedia the free encyclopedia jump to navigation search david kalergis born december   is an american life sciences entrepreneur and the cofounder and chief executive officer of diffusion pharmaceuticals inc a charlottesville virginia usbased biotechnology and pharmaceutical company he cofounded the company in  with american chemical engineer john l gainer kalergis became diffusions ceo in  a position in which he has drawn extensively on his career in law business and clinical trials implementation under kalergis’ leadership diffusion pharmaceuticals has been cited for advancing improved cancer treatments and is currently conducting multicenter clinical trials of a novel therapeutic for brain cancers including glioblastoma multiforme david kalergis contents  education and career  other activities  awards and books  references education and careeredit kalergis received a ba degree in psychology in  and jd and mba degrees in  from the university of virginia he subsequently worked with the new yorkbased law firm dewey ballantine bushby palmer  wood maintaining that association until  when he became president and general counsel of designs importexport ltd from  to  he was consultant director of business development and general counsel to the contract research organization pharmaceutical research associates pra inc while with pra he was involved in numerous pharmaceutical development projects through the preclinical clinical and postmarketing stages in  kalergis was appointed director of university of virginia gateway a program to establish stronger ties between industry and academia particularly in the area of life sciences his efforts have been cited in advancing relationships between the hightechnology business and academic sectors both regionally  and internationally it was through his association with the university of virginia that kalergis met gainer who was at that time a professor of chemical engineering leading to their collaboration in the founding of diffusion pharmaceuticals kalergis is also a graduate of the harvard business school’s leadership and strategy in biotechnology and pharmaceuticals program other activitiesedit kalergis is a founding director of publicly traded virginia national bank where he was chairman of the assets and liabilities committee and a member of the audit committee he is a former member of the boards of directors of the virginia biotechnology association the virginia piedmont technology council and the computerskids program in charlottesville virginia he is a member of the new york and virginia state bar associations awards and booksedit kalergis received the virginia piedmont technology councils navigator award in  his and gainers work at diffusion pharmaceuticals was acknowledged in  when the company received the virginia healthcare innovators “medical product or device” award kalergis is the author of the role of the university in the commercialization of biotechnology  referencesedit  a b c d david kalergis walker research retrieved november     a b david kalergis forbes retrieved november     two local firms head to clinical trial stage for cancer treatment medications the daily progress february   retrieved december     area biotech groups lead the charge the daily progress february   retrieved december     company overview of diffusion pharmaceuticals llc bloomberg businessweek retrieved november     safety and efficacy study of trans sodium crocetinate tsc with concomitant radiation therapy and temozolomide in newly diagnosed glioblastoma gbm clinicaltrialsgov november  retrieved september     a b c d executive profile david g kalergis jd mba bloomberg businessweek retrieved november     virginia gateway in the news gateway  archived from the original on april   retrieved december     uva building japanese partnerships patent foundation opens licensing office in kobe insideuva january –  archived from the original on december   retrieved december     diffusion pharmaceuticals wins  va healthcare innovators award virginia biotechnology association retrieved october    retrieved from httpsenwikipediaorgwindexphptitledavidkalergisoldid categories american chief executivesuniversity of virginia school of law alumniuniversity of virginia darden school of business alumni birthsliving people navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david kalergis  wikipedia david kalergis from wikipedia the free encyclopedia jump to navigation search david kalergis born december   is an american life sciences entrepreneur and the cofounder and chief executive officer of diffusion pharmaceuticals inc a charlottesville virginia usbased biotechnology and pharmaceutical company he cofounded the company in  with american chemical engineer john l gainer kalergis became diffusions ceo in  a position in which he has drawn extensively on his career in law business and clinical trials implementation under kalergis’ leadership diffusion pharmaceuticals has been cited for advancing improved cancer treatments and is currently conducting multicenter clinical trials of a novel therapeutic for brain cancers including glioblastoma multiforme david kalergis contents  education and career  other activities  awards and books  references education and careeredit kalergis received a ba degree in psychology in  and jd and mba degrees in  from the university of virginia he subsequently worked with the new yorkbased law firm dewey ballantine bushby palmer  wood maintaining that association until  when he became president and general counsel of designs importexport ltd from  to  he was consultant director of business development and general counsel to the contract research organization pharmaceutical research associates pra inc while with pra he was involved in numerous pharmaceutical development projects through the preclinical clinical and postmarketing stages in  kalergis was appointed director of university of virginia gateway a program to establish stronger ties between industry and academia particularly in the area of life sciences his efforts have been cited in advancing relationships between the hightechnology business and academic sectors both regionally  and internationally it was through his association with the university of virginia that kalergis met gainer who was at that time a professor of chemical engineering leading to their collaboration in the founding of diffusion pharmaceuticals kalergis is also a graduate of the harvard business school’s leadership and strategy in biotechnology and pharmaceuticals program other activitiesedit kalergis is a founding director of publicly traded virginia national bank where he was chairman of the assets and liabilities committee and a member of the audit committee he is a former member of the boards of directors of the virginia biotechnology association the virginia piedmont technology council and the computerskids program in charlottesville virginia he is a member of the new york and virginia state bar associations awards and booksedit kalergis received the virginia piedmont technology councils navigator award in  his and gainers work at diffusion pharmaceuticals was acknowledged in  when the company received the virginia healthcare innovators “medical product or device” award kalergis is the author of the role of the university in the commercialization of biotechnology  referencesedit  a b c d david kalergis walker research retrieved november     a b david kalergis forbes retrieved november     two local firms head to clinical trial stage for cancer treatment medications the daily progress february   retrieved december     area biotech groups lead the charge the daily progress february   retrieved december     company overview of diffusion pharmaceuticals llc bloomberg businessweek retrieved november     safety and efficacy study of trans sodium crocetinate tsc with concomitant radiation therapy and temozolomide in newly diagnosed glioblastoma gbm clinicaltrialsgov november  retrieved september     a b c d executive profile david g kalergis jd mba bloomberg businessweek retrieved november     virginia gateway in the news gateway  archived from the original on april   retrieved december     uva building japanese partnerships patent foundation opens licensing office in kobe insideuva january –  archived from the original on december   retrieved december     diffusion pharmaceuticals wins  va healthcare innovators award virginia biotechnology association retrieved october    retrieved from httpsenwikipediaorgwindexphptitledavidkalergisoldid categories american chief executivesuniversity of virginia school of law alumniuniversity of virginia darden school of business alumni birthsliving people navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david kalergis  wikipedia david kalergis from wikipedia the free encyclopedia jump to navigation search david kalergis born december   is an american life sciences entrepreneur and the cofounder and chief executive officer of diffusion pharmaceuticals inc a charlottesville virginia usbased biotechnology and pharmaceutical company he cofounded the company in  with american chemical engineer john l gainer kalergis became diffusions ceo in  a position in which he has drawn extensively on his career in law business and clinical trials implementation under kalergis’ leadership diffusion pharmaceuticals has been cited for advancing improved cancer treatments and is currently conducting multicenter clinical trials of a novel therapeutic for brain cancers including glioblastoma multiforme david kalergis contents  education and career  other activities  awards and books  references education and careeredit kalergis received a ba degree in psychology in  and jd and mba degrees in  from the university of virginia he subsequently worked with the new yorkbased law firm dewey ballantine bushby palmer  wood maintaining that association until  when he became president and general counsel of designs importexport ltd from  to  he was consultant director of business development and general counsel to the contract research organization pharmaceutical research associates pra inc while with pra he was involved in numerous pharmaceutical development projects through the preclinical clinical and postmarketing stages in  kalergis was appointed director of university of virginia gateway a program to establish stronger ties between industry and academia particularly in the area of life sciences his efforts have been cited in advancing relationships between the hightechnology business and academic sectors both regionally  and internationally it was through his association with the university of virginia that kalergis met gainer who was at that time a professor of chemical engineering leading to their collaboration in the founding of diffusion pharmaceuticals kalergis is also a graduate of the harvard business school’s leadership and strategy in biotechnology and pharmaceuticals program other activitiesedit kalergis is a founding director of publicly traded virginia national bank where he was chairman of the assets and liabilities committee and a member of the audit committee he is a former member of the boards of directors of the virginia biotechnology association the virginia piedmont technology council and the computerskids program in charlottesville virginia he is a member of the new york and virginia state bar associations awards and booksedit kalergis received the virginia piedmont technology councils navigator award in  his and gainers work at diffusion pharmaceuticals was acknowledged in  when the company received the virginia healthcare innovators “medical product or device” award kalergis is the author of the role of the university in the commercialization of biotechnology  referencesedit  a b c d david kalergis walker research retrieved november     a b david kalergis forbes retrieved november     two local firms head to clinical trial stage for cancer treatment medications the daily progress february   retrieved december     area biotech groups lead the charge the daily progress february   retrieved december     company overview of diffusion pharmaceuticals llc bloomberg businessweek retrieved november     safety and efficacy study of trans sodium crocetinate tsc with concomitant radiation therapy and temozolomide in newly diagnosed glioblastoma gbm clinicaltrialsgov november  retrieved september     a b c d executive profile david g kalergis jd mba bloomberg businessweek retrieved november     virginia gateway in the news gateway  archived from the original on april   retrieved december     uva building japanese partnerships patent foundation opens licensing office in kobe insideuva january –  archived from the original on december   retrieved december     diffusion pharmaceuticals wins  va healthcare innovators award virginia biotechnology association retrieved october    retrieved from httpsenwikipediaorgwindexphptitledavidkalergisoldid categories american chief executivesuniversity of virginia school of law alumniuniversity of virginia darden school of business alumni birthsliving people navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view david g kalergis jd mba executive profile  biography  bloomberg july    am et biotechnology company overview of diffusion pharmaceuticals inc snapshotpeople  overviewboard memberscommittees executive profile david g kalergis jd mbacofounder chairman  ceo diffusion pharmaceuticals incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background mr david g kalergis jd mba is cofounder of diffusion pharmaceuticals llc and serves as its chairman and chief executive officer mr kalergis has overall responsibility for implementing the diffusions strategy as established by the board of directors as well as handling daytoday operational matters mr kalergis served as the chairman of the board and chief executive officer at restorgenex corporation since january   from  to  mr kalergis  served as the president and general counsel of designs importexport ltd from  to  he served as general counsel director of business development and consultant to pharmaceutical research associates inc he serves as a director of university of virginia gateway he serves as an director of diffusion pharmaceuticals llc mr kalergiss duties at gateway began on february   he serves on the board of the virginia piedmont technology council and the computersklds program he served as a director of virginia national bank and virginia national bankshares corporation from  to  he was associated with the new york law firm of dewey ballantine bushby palmer  wood in  he was awarded the virginia piedmont technology councils navigator award for his leadership and contributions to the technology community and the regions economic development he is a member of the new york and virginia state bar associations and is the author of the role of the university in the commercialization of biotechnology  mr kalergis is a graduate of the harvard business schools leadership and strategy in biotechnology and pharmaceuticals program mr kalergis graduated from the university of virginia with a ba degree in psychology in  in  he received jd and mba degrees from the university of virginiaread full background corporate headquarters  avon courtcharlottesville virginia united statesphone fax  board members memberships presentcofounder chairman  ceodiffusion pharmaceuticals inc education jd university of virginiaba university of virginiamba university of virginia other affiliations restorgenex corporationvirginia national bankshares corporationuniversity of virginia annual compensation salarytotal annual compensation stocks options all other compensationexercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact diffusion pharmaceuticals inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close david g kalergis co  founder dir ceo diffusion pharmaceuticals llc a publisher of business information since         search business search executive   advanced search   sign in    hints profile of david kalergis   david kalergis   co  founder dir ceo  diffusion pharmaceuticals llc   david kalergis email  please login   company name  diffusion pharmaceuticals llc   company website  wwwdiffusionpharmacom   company address   avon ctno  charlottesville vaunited states   david kalergis profile  co  founder dir ceo  diffusion pharmaceuticals llc   david kalergis biography  david kalergis has extensive experience with the commercialization of university research especially in the area of pharmaceuticals and biotechnology as ceo of the company mr kalergis has overall responsibility for implementing the company’s strategy as established by the board of directors as well as handling daytoday operational matters immediately prior to joining diffusion pharmaceuticals he was director of the university of virginia’s gateway initiative dedicated to linking the research activities of the university with the high technology business community in  he was awarded the virginia piedmont technology council’s navigator award for his leadership and contributions to the technology community and the region’s economic development from  to  mr kalergis was general counsel director of business development and consultant to pharmaceutical research associates inc pra a contract research firm providing drugdevelopment services to the worldwide pharmaceutical and biotechnology industries he also served on pra’s board of directors in these roles he was involved in the business financial planning and clinical trials implementation of dozens of pharmaceutical compounds in all stages of development ranging from preclinical through postmarketing mr kalergis currently serves on a number of boards of directors in addition to diffusion pharmaceuticals including the virginia biotechnology association he is a founding director of publiclytraded virginia national bank trading symbol vabk and serves on its audit committee and as chairman of its community committee mr kalergis is a graduate of the harvard business school’s leadership and strategy in biotechnology and pharmaceuticals program he holds ba mba and jd degrees from the university of virginia is a member of the new york and virginia state bar associations and is the author of the role of the university in the commercialization of biotechnology    david kalergis colleagues  name title email john gainer co  founder dir chief scientific advisor please login matthew hantzmon vp  business development please login ben shealy cfo company officer please login christopher dvergsten sr dir  scientific affairs please login kim whitten dir  clinical development please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory        walkerss research  a publisher of business information since  all rights reserved diffusion pharmaceuticals inc  board of directors about uscompany overview management team board of directors scientific advisory board intellectual property careers newspress releases scientific conferences newsletter board of directors titlebio david g kalergis jdmba chairman of the board  chief executive officer david kalergis is the cofounder of diffusion pharmaceuticals inc and has served as the company’s chief executive officer since  under his leadership diffusion has grown into a publiclytraded clinicalstage drug development company commercializing a novel proprietary pharmaceutical technology clinical trials of diffusion’s lead compound trans sodium crocetinate tsc began in  with a focus on improved treatments for solid cancerous tumors tsc in newly diagnosed glioblastoma gbm was the subject of a successful endofphase  meeting with the fda in  and the company is now working on the implementation of phase  programs before attending graduate school david worked as an intelligence analyst for the us government in  after receiving mba and jd degrees from the university of virginia he was associated with the new york city law firm of dewey ballantine bushby palmer  wood practicing in the areas of corporate finance public offerings and mergers and acquisitions in  david became the first private investor in pharmaceutical research associates inc pra a contract research organization providing clinical trials services to international pharmaceutical and biotechnology companies pra went public in  and is now among the world’s largest cros david served on pra’s board of directors and from  to  first as head of business development and then as general counsel in these capacities he was involved in the planning and implementation of all phases of pharmaceutical clinical trials across a wide range of indications after leaving pra david became associated with the university of virginia in an initiative to more closely link hightechnology industry with research he met professor john gainer and the two launched diffusion pharmaceuticals shortly thereafter david has remained involved with the university’s efforts to encourage the spinout of new high technology companies david is a founding director of publicly traded virginia national bank and served on its board until may  while on the virginia national bank board he served on its audit committee and as chairman of its assets and liabilities committee other past board service includes the virginia biotechnology association david graduated from the university of virginia college of arts and sciences with a ba in psychology in  he graduated from the combined program of the colgate darden graduate school of business administration and the university of virginia school of law receiving both jd and mba degrees david is also a graduate of the harvard business school’s leadership and strategy in the pharmaceutical and biotechnology industry program titlebio isaac blech vice chairman of the board mr blech an experienced biotechnology entrepreneur and investor brings to diffusion over  years of expertise in the biotech industry he has founded and served on the board of a number of companies that have produced major advances in a broad array of diseases including the diagnosis of chlamydia herpes syphilis and hiv and the treatment of cystic fibrosis sexual dysfunction multiple myeloma and many forms of cancer and hematological disease among the companies he has established are celgene corporation the world’s leading company in cancer and hematology icos corporation that developed the drug cialis and was purchased by eli lilly nova pharmaceutical corporation that developed a new treatment for brain cancer gliadel and was purchased by johnson  johnson pathogenesis corporation that developed the leading drug for cystic fibrosis and was purchased by chiron and genetics systems corporation that developed the first rapid accurate diagnostic for chlamydia and the first accurate test to safe guard the world’s blood supply from the aids virus and was later purchased by bristolmyers squibb among the boards mr blech currently serves on are cerecor inc a cns company contrafect corporation an infectious disease company medgenics inc a biotechnology company and edge therapeutics inc a company that treats lifethreatening neurological conditions titlebio john l gainer phd chief scientific officer  company cofounder dr john l gainer was professor of chemical engineering at the university of virginia serving as a member of the faculty from  as cofounder and chief scientific advisor of the company and the inventor of the trans bipolar carotenoid family of molecules he plays a critical role in charting the path of their further development and commercialization he has authored more than  scientific journal articles including more than  published in medical journals he has spent four decades investigating the transport properties of small molecules in solvents and biological systems his recent research funded by onr has focused on the use of trans bipolar carotenoid molecules to treat hemorrhagic shock which is the major cause of death in combat and to treat acute respiratory distress syndrome ards professor gainer has spent two sabbaticals investigating drug actions and related research in the laboratories of major pharmaceutical companies he has been a member of the international society for oxygen transport in tissues since its inception in  he has received several teaching awards including the university of virginia alumni association’s distinguished professor award and the outstanding teacher award from the southeastern section of the american society for engineering education dr gainer received his phd in chemical engineering from the university of delaware in  titlebio robert adams jd member chairman of the compensation committee robert w adams esq serves as a director on the company’s board mr adams was until his recent retirement partner in the intellectual property law firm of nixon  vanderhye pc arlington va he is a member of the virginia state bar and the international trademark association his practice specialty over the past  years has been us patent litigation and international patent licensing and negotiations mr adams received a ba from the university of maryland in  and a jd with honors from george washington university in  titlebio mark t giles jd member chairman of the nominating and governance committee mr giles has served as a director since the completion of the merger in january  and as a director of diffusion llc since  since july  mr giles has been the sole managing member of panda holdings llc which engages in the investment and management of private capital prior to joining panda holdings mr giles served as the chief executive officer of virginia national bank from july  until june  and thereafter continued to serve as the nonexecutive chairman until december  prior to joining virginia national bank mr giles also served as the president of two publicly traded bank holding companies and subsidiary banks in texas and practiced law with the banking group of a houston law firm he chairs the board of expedition trust company and is a director of door to door organics inc  mr giles received a bs from the mcintire school of commerce at the university of virginia and a jd from the university of virginia school of law titlebio alan levin member chairman of the audit comittee alan levin formerly served as executive vice president  chief financial officer of endo health solutions inc endo from june  until september  prior to joining endo mr levin worked with texas pacific group a leading private equity firm and one of their startup investments before that he was senior vice president  chief financial officer of pfizer inc where he worked for  years in a variety of executive positions of increasing responsibility mr levin received a bachelor’s degree from princeton university and a master’s degree from new york university’s stern school of business he is a certified public accountant and a member of the advisory board of auven therapeutics a private equity fund where he chairs the fund’s audit  risk committee he is also a member of the board of directors of aceto corp a nasdaqtraded company specialized in generics and pharmaceutical intermediate products and the critical path institute a nonprofit collaboration between the food and drug administration and the pharmaceutical industry focused on streamlining and accelerating the development and regulatory pathways for innovative medicines david g kalergis esq  charlottesville va  lawyercom ask a lawyer tell us your case information for fastest lawyer match please include all relevant details from your case including where when and who it involves case details that can effectively describe the legal situation while also staying concise generally receive the best responses from lawyers briefly describe your case your contact info name cell phone number email your case location zip by submitting this lawyer request i confirm i have read and agree to the consent to receive email phone text messages terms of use and privacy policy information provided may not be privileged or confidential david g kalergis esq at charlottesville virginia david g kalergis esq david g kalergis esq general practice  barracks road  charlottesville va is this your firmupgrade to a premium listing contact david g kalergis esq briefly describe your case your contact info your case location   free also send inquiry to other qualified local lawyers by submitting this lawyer request i confirm i have read and agree to the consent to receive email phone text messages terms of use and privacy policy information provided may not be privileged or confidential lawyers david g kalergis general practice  charlottesville va  albemarle county profile lawpoints™ law firms nearby law offices of christopher j smith pc divorce  family law wills  probate misdemeanor landlordtenant power of attorney ✓ lawyercom featured contact charlottesville va  uva law administrative law contact charlottesville va  charlottesville city county ainsworth thelin  raftice pa general practice law firm contact charlottesville va  charlottesville city county morris law office pc general practice law firm contact charlottesville va  albemarle county david j feigert general practice law firm contact charlottesville va  charlottesville city county catherine stuart greer esq llc general practice law firm contact charlottesville va  albemarle county view more law firms nearby  main location  barracks roadcharlottesville va  sample legal cases dhs secretary john kelly appoints julie kirchner as new cis ombudsman on may   secretary of homeland security john kelly announced the appointment of julie kirchner as the cis ombudsman named to florida trend’s  legal elite for business litigation aaron resnick esq has been named to florida trend’s  legal elite™ for business litigation the state’s top lawyers are recognized in the  edition of florida trend’s florida legal elite™ kodak black sued for skipping a concert to go on vacation the law offices of aaron resnick pa’s recent lawsuit for clients suing famous rap artist kodak black was recently featured in the broward new times a good cover letter makes a resume shine an article marketing strategy for writers can be greatly improved by using a content spinner in the form of writing most writers think that using an article spinner is beneath them they let pride stand it the way of maximizing their income generation potential get more follower on instagram best sites instagram seriously isn’t only the put to entertain but also a wonderful platform to expose and grow any kind of techniques it provides the simplest and specific way to developed into an effective icon inside most competitive society sure it can be social websites advertising papers writing service wholesale writemypaperio gives a wide range of writing solutions to support your scholastic needs our professional services are provided by expert writers who may be professional in a variety of investigation subject areas and subject matter automobile wrecks involving a car and suv  st louis lawyers according to a recent study when an suv collided with a passenger car of a smaller size the death rate of those in the passenger car was  times higher than the death rate of those in the suv eoir announces plans to relocate las vegas immigration court on may  the executive office of immigration review eoir announced that it will temporarily close its las vegas immigration court at noon on may  in order to prepare for relocating the court the las vegas immigration court will recommence hearings at its new location on may  usa today reports apparent slowdown in refugee admissions on may   alan gomez of usa today reported that refugee admissions have dropped sharply in march and april according to the report the united states admitted  refugees in march which represented the lowest total since  and  refugees in april house passes working families flexibility act of   analysis and discussion on may   the united states house of representatives passed the working families flexibility act of  on a mostly partyline vote of  what is employee misclassification as independent contractors so whats the difference between an employee and an independent contractor and what is employee misclassification  awesome reasons to become a lawyer see what makes one want to become a lawyer and what are the perks lawyers enjoy summer newlyweds should also think about taxes spring showers bring summer flowers and weddings typically aren’t far behind newlyweds have a lot to think about and taxes might not be on the list lawyer says he missed deposition because email notice went to his junk folder so there is still use for certified mail after all us reportedly defines ‘close family’ ties that will exempt immigrants from travel ban the us state department has reportedly adopted guidelines to define which immigrants are exempt from the revised ban on travel to the united states by people from six muslimmajority countries fake law firm website uses real lawyers’ pictures to fleece consumers bar lawsuit says the houston bar association has filed a lawsuit seeking to shut down a fake law firm website that is using the pictures of real lawyers in an apparent scam targeting elderly people lawyer says he missed deposition because email notice went to his junk folder so there is still use for certified mail after all summer newlyweds should also think about taxes spring showers bring summer flowers and weddings typically aren’t far behind newlyweds have a lot to think about and taxes might not be on the list senate confirms alexander acosta as secretary of labor on april   the senate confirmed alexander acosta as secretary of labor by a vote of  secretary acosta was sworn into office one day later the confirmation completed president donald trumps cabinet when employees take workplace communication offline today many people prefer texting over many other forms of communication such as calling or emailing the recipient this is an efficient form of communication because individuals can send a quick message about something important to them within a few seconds rather than being busy   quicksearch  near go lawyer search legal protection plan for lawyers my account about us broad search keyword practice area please select optional accident  injury     all accident  injury     animal bite     asbestos  mesothelioma     aviation accident     car accident     defamation  slander     malpractice     medical malpractice     personal injury     products liability     property damage     railroad injury     slip  fall accident     toxic mold  tort     workers compensation     wrongful deathbankruptcy  debt     all bankruptcy  debt     bankruptcy     collection     credit  debt     reorganization     workoutbusiness     all business     administrative law     antitrust     banking  finance     business organization     contract     corporate     insurance     merger  acquisition     securitiescivil  human rights     all civil  human rights     civil rights     constitutional law     discrimination     elder law     native peopleconsumer rights     all consumer rights     consumer protection     identity theftcriminal     all criminal     duidwi     felony     misdemeanor     rico act     traffic     white collar crimedivorce  family law     all divorce  family law     adoption     child custody     child support     divorce     family lawemployment     all employment     employee rights     employment contracts     employment discrimination     family medical leave act fmla     labor law     occupational safety  health     pension  benefits     sexual harassment     whistleblower     workers compensation     wrongful terminationenvironmental law     all environmental law     natural resources     waste  pollution     environmental law otherestate     all estate     estate planning     power of attorney     trusts     wills  probategovernment     all government     election  political     government agencies     government contract     legislative practice     permits     public interest law     social security     state and local     us courts     welfarehealth care     all health care     medical products  devices     medicare  medicaid     pharmaceutical product     health care otherimmigration     all immigration     deportation     visaindustry specialties     all industry specialties     admiralty  maritime     advertising     agriculture     aviation     communication  media law     energy     entertainment     gaming  alcohol     oil  gas     science technology  internet     transportation  shipping     other industriesintellectual property     all intellectual property     copyright     international intellectual property     patent     trademarkinternational     all international     foreign investment     international tax     international trade     international otherlawsuit  dispute     all lawsuit  dispute     arbitration     class action     dispute resolution     lawsuit     litigation     mediationmotor vehicle     all motor vehicle     defect and lemon law     trafficreal estate     all real estate   timeshare     construction     eminent domain     foreclosure     land use  zoning     landlordtenant     real estate othertax     all tax     corporate tax     income tax     sales  use tax     tax litigationother     all other     education     ethics     juvenile law     military     power of attorney location miles search advanced search lawyers law firms practice areas international articles law schools resources lawyercom legal protection plan prepaid legal service that can help youand your family save money withaffordable family legal insurance unlimited minute free consultations save  on legal fees up to  million identity theft protectionand more   see all benefits » join now premium membership for lawyers benefits partner discounts preferred partners law firms additional services lawyerline™ lawsite express topfirm listings adwords review jumpstart package seo review website evaluation resources profile lawpoints sponsorships legal articles cle class seconds count international my account details member login page forgot password new user sign up log in to lawyercom log in company information lawyercom team company culture news  press releases contact us lawyer faq testimonials privacy policy settlement blog legal marketing blog david kalergis quizzes  lists  trending sign up  login feedback david kalergis topics  videos  discussion  writeups back to top  revolvy llc mobile terms privacy contact paste image information here × image source save changes × cancel  × × done cancel by proceeding i agree to the revolvy terms of service and privacy policy ok cancel ok cancel × ok cancel × ok cancel × ok cancel × save cancel × ok clear cancel × ok clear cancel david g kalergis  cofounder at diffusion pharmaceuticals inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink david g kalergis cofounder at diffusion pharmaceuticals inc overview in the news relationships paths education career history boards  committees political donations public holdings transactions david g kalergis cofounder at diffusion pharmaceuticals inc overview age  born  notable companies pharmaceutical research associates inc designs import export ltd restorgenex corp board seats  number of relationships this person is connected to  people in the news see more marketline newswire july   diffusion announces update on phase iii brain cancer trial globenewswire july   diffusion pharmaceuticals achieves drug production milestone for planned phase  clinical trial in inoperable gbm brain cancer globenewswire july   diffusion pharmaceuticals appoints dr robert ruffolo to board of directors globenewswire may   diffusion pharmaceuticals provides corporate highlights and reports financial first quarter  results globenewswire april   diffusion pharmaceuticals awarded us patent for tsc as therapeutic in five hypoxiarelated indications see full news coverage and complete stories with relsci professional create your news feed see more relationships see details john l gainer cofounder at diffusion pharmaceuticals inc mark t giles managing member at panda holdings llc thomas e byrne secretary  general counsel at diffusion pharmaceuticals inc alan g levin editorial advisor at journal of accountancy robert w adams attorney at nixon  vanderhye pc isaac blech founder  director at cerecor inc david r jones chief medical officer at diffusion pharmaceuticals inc robert r ruffolo jr advisor partnerships  rd initiatives at hemoshear llc stephen m siems former president  chief executive officer at ani pharmaceuticals inc david sherris president  chief executive officer at paloma pharmaceuticals inc see  more listings with relsci professional start my free trial ➤ see  more paths to david g kalergis david g kalergis you connections via relationship science david g kalergis sync your contacts to see how you can connect with david g kalergis start my free trial ➤ see more educational background   university of virginia the university of virginia often abbreviated as uva uva or virginia is a public research university in charlottesville virginia united states it was conceived and designed by us president thomas jefferson and established in  uvas initial board of visitors included former presidents of the united states thomas jefferson james madison and james monroe monroe owned the initial site of the university which was mostly farmland his law office and farmhouse are now the site of brown college at monroe hill a residential college at uva uva is one of the eight original public ivy universities and it is the only university campus in the united states that is designated a world heritage site by unesco in the  edition of us news and world reports national university rankings the school was listed as americas nd best public university tied with ucla and surpassed only by uc berkeley career history cofounder   current diffusion pharmaceuticals inc diffusion pharmaceuticals inc is a clinical stage company which engages in the provision of oncologyfocused biotechnology it involves in research and development and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy the company was founded by david g kalergis and john l gainer in  and is headquartered in charlottesville va chief executive officer   prior restorgenex corp restorgenex corp operates as a specialty biopharmaceutical company which focuses on developing products for dermatology ophthalmology and oncology it products includes novel pikaktmtor pathway inhibitor which has completed two phase i clinical trials for agerelated macular degeneration and is in preclinical development in oncology specifically glioblastoma multiforme the company current pipeline also includes a soft antiandrogen compound for the treatment of acne vulgaris restorgenex was founded on march   and is headquartered in buffalo grove il chairman  chief executive officer   prior diffusion pharmaceuticals llc diffusion pharmaceuticals llc develops and manufactures pharmaceutical products the firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia oxygen deprivation is known to diminish the effectiveness of current treatments the company was founded by matthew w hantzmon john l gainer and david g kalergis in february  and is headquartered in charlottesville va directorbusiness development  general counsel    pharmaceutical research associates inc pharmaceutical research associates inc provides clinical research services they offer different clinical trials in the pharmaceutical and biotech drug development industry the company was founded in  and is headquartered in raleigh nc president  general counsel    designs import export ltd boards  committees corporate boards ▾ chairman board of directors   current diffusion pharmaceuticals inc diffusion pharmaceuticals inc is a clinical stage company which engages in the provision of oncologyfocused biotechnology it involves in research and development and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy the company was founded by david g kalergis and john l gainer in  and is headquartered in charlottesville va chairman board of directors   prior restorgenex corp restorgenex corp operates as a specialty biopharmaceutical company which focuses on developing products for dermatology ophthalmology and oncology it products includes novel pikaktmtor pathway inhibitor which has completed two phase i clinical trials for agerelated macular degeneration and is in preclinical development in oncology specifically glioblastoma multiforme the company current pipeline also includes a soft antiandrogen compound for the treatment of acne vulgaris restorgenex was founded on march   and is headquartered in buffalo grove il director   prior diffusion pharmaceuticals llc diffusion pharmaceuticals llc develops and manufactures pharmaceutical products the firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia oxygen deprivation is known to diminish the effectiveness of current treatments the company was founded by matthew w hantzmon john l gainer and david g kalergis in february  and is headquartered in charlottesville va independent director   prior virginia national bank charlottesville virginia national bank provides banking and financial services the firm operates through two segments the commercial bank and vnb trust the commercial bank segment involves making loans and generating deposits from individuals and businesses the vnb trust segment offers services which include investment management trust account administration and estate planning it offers personal banking business banking and treasury management services the company was founded on july   and is headquartered in charlottesville va nonprofit boards ▾ director    university of virginia the university of virginia often abbreviated as uva uva or virginia is a public research university in charlottesville virginia united states it was conceived and designed by us president thomas jefferson and established in  uvas initial board of visitors included former presidents of the united states thomas jefferson james madison and james monroe monroe owned the initial site of the university which was mostly farmland his law office and farmhouse are now the site of brown college at monroe hill a residential college at uva uva is one of the eight original public ivy universities and it is the only university campus in the united states that is designated a world heritage site by unesco in the  edition of us news and world reports national university rankings the school was listed as americas nd best public university tied with ucla and surpassed only by uc berkeley director prior virginia biotechnology association virginia biotechnology association is an american private company located in richmond va the firm promotes biotechnology industry it was founded by terry r woodworth jeffrey m gallagher is the current ceo occupying that position since  political donations   john wade douglass former president  chief executive officer at aerospace industries association   ernest wayne powell resident  partner at powell  parrish pc   thomas stuart price perriello cofounder at avaaz foundation   thomas stuart price perriello cofounder at avaaz foundation   stephen c shannon see  more listings with relsci professional start my free trial ➤ see  more public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden diffusion pharmaceuticals inc raised money in a private placement transaction details hidden diffusion pharmaceuticals inc raised money in a private placement transaction details hidden diffusion pharmaceuticals llc raised money in a private placement transaction details hidden diffusion pharmaceuticals llc raised money in a private placement transaction details hidden diffusion pharmaceuticals llc raised money in a private placement transaction see  more listings with relsci professional start my free trial ➤ see  more other affiliations david g kalergis is affiliated with diffusion pharmaceuticals inc restorgenex corp diffusion pharmaceuticals llc pharmaceutical research associates inc designs import export ltd diffusion pharmaceuticals inc restorgenex corp diffusion pharmaceuticals llc virginia national bank charlottesville university of virginia virginia biotechnology association youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤